Trans Genic Inc. | Cash Flow

Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
98,946.00
9,396.00
18,959.00
81,933.00
14,459.00
202,875
Depreciation, Depletion & Amortization
84,797.00
94,317.00
103,551.00
112,447.00
143,896.00
190,446
Other Funds
-
307.00
10,999.00
-
57,805.00
76,979
Funds from Operations
11,439.00
96,556.00
122,075.00
246,354.00
101,953.00
470,301
Changes in Working Capital
130,064.00
4,685.00
92,293.00
13,541.00
117,106.00
322,610
Net Operating Cash Flow
141,503.00
101,241.00
214,368.00
232,813.00
219,059.00
147,691
Capital Expenditures
108,246.00
47,005.00
105,868.00
130,095.00
74,093.00
Sale of Fixed Assets & Businesses
66,514.00
-
-
3,000.00
-
Purchase/Sale of Investments
66,110.00
1,342.00
554,236.00
75,974.00
7,098.00
Net Investing Cash Flow
174,871.00
46,550.00
664,721.00
200,101.00
552,120.00
Issuance/Reduction of Debt, Net
111,928.00
92,390.00
69,414.00
73,713.00
58,705.00
Net Financing Cash Flow
371,304.00
92,697.00
157,921.00
27,298.00
1,044,975.00
Net Change in Cash
54,930.00
38,006.00
292,432.00
5,426.00
713,319.00
Free Cash Flow
245,369.00
57,536.00
118,725.00
105,720.00
144,966.00
Net Assets from Acquisitions
191,322.00
-
-
-
465,435.00
Other Sources
7,345.00
1,797.00
6,880.00
2,967.00
123,131.00
Change in Capital Stock
483,232.00
-
77,508.00
46,415.00
1,044,075.00
Exchange Rate Effect
-
-
-
12.00
1,405.00
Other Uses
15,272.00
-
11,497.00
-
128,624.00

About Trans Genic

View Profile
Address
ibb Fukuoka, 2/F
Fukuoka Fukuoka 810
Japan
Employees -
Website http://www.transgenic.co.jp
Updated 07/08/2019
Trans Genic Inc. engages in the research and development, distribution, and licensing of genetically engineered animals and antibodies. It operates through the following segments: Genomics, CRO Business, Antibody and Reagent, and Pathological Diagnosis. The Genomics segment conducts contract knockout mouse production, gene analysis service, and sales of disease-model mouse.